Jing Liu

Dr. Jing Liu is a Research Fellow at the Max Planck Institute for Terrestrial Microbiology in Marburg, Germany, working within the Bode Research Group led by Prof. Helge Bode. Her position focuses on microbial natural product biosynthesis, utilizing genomic and biochemical approaches to investigate enzymatic mechanisms in secondary metabolism.

Dr. Liu's research centers on the enzymology of bacterial secondary metabolite pathways, particularly diketopiperazine derivatives and related compounds. She specializes in characterizing cytochrome P450 enzymes, prenyltransferases, and oxidases involved in regiospecific modifications such as prenylation, guaninylation, and C-C bond formation. Her work bridges microbiology, biochemistry, and drug discovery to elucidate biosynthetic pathways for anti-infective agents.

Analysis of her 15 most recent publications (2012-2023) reveals consistent focus on Streptomyces-derived natural products, with emphasis on genomic-guided discovery of biosynthetic gene clusters and enzymatic characterization of novel catalytic mechanisms. Key trends include regiospecific enzymatic modifications generating structural diversity in diketopiperazines, and exploration of enzyme promiscuity for metabolic engineering applications.

No scientific awards were documented in the available source material.

As a Research Fellow, Dr. Liu conducts independent research under Prof. Bode's mentorship. The source material contains no information regarding student supervision, grant funding, or collaborative projects beyond her core research activities.

Dr. Liu operates within the Bode Research Group, which employs integrated approaches combining microbial genetics, enzymology, and analytical chemistry to investigate bacterial secondary metabolism. The group specializes in elucidating biosynthetic pathways for bioactive natural products with pharmaceutical potential.